5.2 Opioid Controls, APRN/PA Schedule II Limits & Naloxone

5.2 Georgia Opioid Controls, APRN/PA Schedule II Limits & Naloxone Standing Order

Georgia’s opioid-safety framework for the MPJE mixes prescriber PDMP duties, mid-level Schedule II emergency limits, pharmacist corresponding responsibility, and a statewide naloxone standing order. A common third-party study trap is inventing a universal “5-day acute pain opioid limit” for every Georgia practitioner. That is not how Georgia law is written. Learn the actual Rule 480-22 and PDMP rules instead.

What Georgia Does Not Generally Require

Unlike some states that enacted a blanket acute-pain days-supply cap for all clinicians, Georgia’s pharmacy Board rules do not state that every physician’s or dentist’s first opioid prescription for acute pain is capped at five days. If an exam item asks about a general 5-day acute-pain cap applying to all Georgia practitioners, treat that claim skeptically and look for the more specific APRN/PA emergency Schedule II rule described below. Pharmacists should still use corresponding responsibility, clinical judgment, and PDMP information when any opioid prescription appears unsafe or inconsistent.

APRN and PA Schedule II Emergency 5-Day Limit (Rule 480-22)

Georgia Board Rule 480-22 implements statutory authority allowing certain advanced practice registered nurses (APRNs) and physician assistants (PAs) to issue limited Schedule II controlled-substance orders in emergency circumstances when specific conditions are met. For those emergency Schedule II orders, the rule limits the drug order to an initial prescription not exceeding a five (5) day supply, and additional conditions apply, including that:

• Authorization to issue the Schedule II order is specifically included in the APRN’s nurse protocol agreement or the PA’s job description.
• The APRN/PA has directly evaluated the patient.
• The patient is an adult (18 years of age or older) under the rule’s stated conditions.
• The APRN/PA holds the required license status/experience described in the rule and related statute.

MPJE takeaway: The tested “5-day” concept in Georgia is tied to mid-level emergency Schedule II authority, not a slogan that “all initial opioids are 5 days.” Always read who the prescriber is and whether the item is describing an emergency APRN/PA Schedule II order.

Prescriber PDMP Duties (HB 249 Framework)

Georgia’s Prescription Drug Monitoring Program (PDMP), administered by the Department of Public Health, is a high-yield overlap with Competency Area 3 (DUR/PMP). In broad outline:

• Prescribers with an active Georgia professional license and DEA registration must register in the GA PDMP.
• A prescriber must check the PDMP before writing a prescription for the first time for benzodiazepines and for opiate drugs or cocaine derivatives listed in Schedule II, then at least every 90 days if therapy continues, subject to statutory exceptions (short supplies and certain institutional/care settings are commonly tested exception themes—verify the current DPH exception list when you study).
• Pharmacies/dispensers must report Schedule II–V dispensing to the PDMP within 24 hours and file zero reports for days with no applicable dispensing.

Pharmacists are not the primary “must query before every opioid Rx” actor under the same mandatory-check statute as prescribers, but they remain responsible for prospective DUR, corresponding responsibility, and accurate/timely PDMP reporting from the pharmacy side.

Pharmacist Corresponding Responsibility & Partial Fills

Federal CSA corresponding-responsibility doctrine still applies in Georgia: a prescription for a controlled substance must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, and the pharmacist shares responsibility for proper dispensing. Red flags (cash-only patterns, early fills, cocktail regimens, geographic anomalies, APRN/PA Schedule II orders that ignore the five-day emergency limit) warrant clarification—not automatic refusal without professional assessment, and not robotic approval.

Partial filling of Schedule II opioids: Under federal CARA rules (and consistent Georgia practice expectations), a patient or pharmacist may partially fill a Schedule II opioid; remaining portions generally must be filled within 30 days of the prescription date, and the total quantity dispensed cannot exceed the quantity prescribed. Document the partial fill meticulously.

Statewide Naloxone Standing Order

Naloxone is an opioid antagonist used to reverse opioid overdose. Georgia’s Commissioner of Public Health / State Health Officer standing order authorizes pharmacies to dispense naloxone to eligible persons or entities—including people at risk of overdose and family, friends, coworkers, first responders, schools, and harm-reduction organizations—without a patient-specific prescription from that person’s own clinician.

Pharmacist operational points

• Dispense an FDA-approved naloxone formulation permitted by the standing order (commonly intranasal 4 mg/0.1 mL devices; other listed IM/IN presentations may also appear on the order’s exhibit).
• Provide counseling on overdose recognition, administration technique, and the need to call emergency services because naloxone can wear off before the opioid does.
• Document the dispense in the pharmacy system, identifying the standing-order issuer as the authorizing prescriber of record as directed by pharmacy policy.
• Georgia’s medical amnesty / good-faith protections encourage seeking help and administering naloxone; pharmacists acting in good faith under the standing order are the intended protected dispensers.

Naloxone access was further reinforced in Georgia policy by removing barriers that previously treated naloxone like an ordinary “dangerous drug” for overdose-prevention distribution—exam items often pair the standing order with “may dispense without a patient-specific Rx.”

Comparison Table (Exam Memory Aid)

For Georgia MPJE success, memorize the real mid-level 5-day Schedule II emergency limit, the PDMP check/report duties, and the naloxone standing order—and refuse the popular but inaccurate “universal 5-day acute opioid” myth.